N-acetyltransferases have an important role in the metabolism of aryla
mine and hydrazine drugs an carcinogens. Human N-acetylation phenotype
may predispose individuals toward a variety of drug and xenobiotic-in
duced toxicities and carcinogenesis. Syrian hamsters express two N-ace
tyltransferase isozymes; one varies with acetylator genotype (polymorp
hic) and has been termed NAT2; the other does not (monomorphic) and ha
s been termed NAT1. The intronless NAT1 coding region was cloned via t
he polymerase chain reaction from homozygous rapid acetylator and homo
zygous slow acetylator congenic and inbred hamster genomic DNA templat
es and sequenced. The NAT1 alleles from the homozygous rapid (NAT1r) a
nd homozygous slow (NAT1s) acetylator hamsters differed in one nucleot
ide, but the mutation is silent with no change in deduced amino acid s
equence. To characterize the enzyme products of the NAT1 alleles, we d
eveloped a prokaryotic-expression system. The NAT1r and NAT1s alleles
were amplified by expression-cassette polymerase chain reaction and su
bcloned into the tac promoter-based plasmid vector pKK223-3 for over-p
roduction of recombinant NAT1 in E. coli strain JM105. induced culture
s from selected NAT1-inserted transformants yielded high levels of sol
uble protein capable of N-acetylation, O-acetylation, and N,O-acetylat
ion. The recombinant NAT1r and NAT1s proteins did not differ in substr
ate specificity, specific activity, Michaelis-Menten kinetic propertie
s, intrinsic stability, and electrophoretic mobility. Also, the over-e
xpressed NAT1 proteins displayed substrate-specificity and electrophor
etic mobilities characteristic of NAT1 isolated from Syrian hamster li
ver and colon cytosols.